← Back
SAN GIOVANNI
December, 06th | 13:30 - 15:00
RETINA FUTURA - SESSION 2 - unconditional support of Ocular Therapeutix
Add to calendar
Chairs: RIZZO STANISLAO, HEIER JEFFREY S., KAISER PETER, VAJZOVIC LEJLA
Advancements in Geographic Atrophy (GA): Current and Emerging Therapies
December, 06th | 13:34 - 13:38
Glycomimetic Nanoparticle AVD-104 in the Management of GA From AMD: Anatomic Outcomes
HASSAN TAREK
Add to calendar
Glycomimetic Nanoparticle AVD-104 in the Management of GA From AMD: Anatomic Outcomes
HASSAN TAREK
Add to calendar
December, 06th | 13:38 - 13:42
OpRegen: Embryonic Stem Cell Derived Therapy for Dry AMD and GA
RIEMANN CHRISTOPHER D.
Add to calendar
OpRegen: Embryonic Stem Cell Derived Therapy for Dry AMD and GA
RIEMANN CHRISTOPHER D.
Add to calendar
December, 06th | 13:42 - 13:46
Fas Inhibition with ONL1204 for the Treatment of GA Secondary to AMD: Results from a Phase 1b Study
VAJZOVIC LEJLA
Add to calendar
Fas Inhibition with ONL1204 for the Treatment of GA Secondary to AMD: Results from a Phase 1b Study
VAJZOVIC LEJLA
Add to calendar
December, 06th | 13:46 - 13:50
C1q inhibition with ANX007: Functional and Structural Protection in dry AMD / GA via a Novel Neuroprotective Mechanism
KAISER PETER
Add to calendar
C1q inhibition with ANX007: Functional and Structural Protection in dry AMD / GA via a Novel Neuroprotective Mechanism
KAISER PETER
Add to calendar
Diabetic Retinal Diseases and Retinal Detachment
December, 06th | 14:00 - 14:04
Outcomes of the HORNBILL Study: Phase 1/2a Trial Investigating BI 764524 in Patients With Diabetic Macular Ischemia
NGUYEN QUAN DONG
Add to calendar
Outcomes of the HORNBILL Study: Phase 1/2a Trial Investigating BI 764524 in Patients With Diabetic Macular Ischemia
NGUYEN QUAN DONG
Add to calendar
December, 06th | 14:04 - 14:08
OCS-01: An emerging topical treatment option for DME
LOEWENSTEIN ANAT
Add to calendar
OCS-01: An emerging topical treatment option for DME
LOEWENSTEIN ANAT
Add to calendar
December, 06th | 14:12 - 14:16
HELIOS: Phase 1 SAFETY Study of AXPAXLI in NPDR
DHOOT DILSHER
Add to calendar
HELIOS: Phase 1 SAFETY Study of AXPAXLI in NPDR
DHOOT DILSHER
Add to calendar
December, 06th | 14:16 - 14:20
Intravitreal Fas inhibitor ONL1204 for Macula-off Rhegmatogenous Retinal Detachment: Results of a Phase 2 Clinical Trial
BORKAR DURGA
Add to calendar
Intravitreal Fas inhibitor ONL1204 for Macula-off Rhegmatogenous Retinal Detachment: Results of a Phase 2 Clinical Trial
BORKAR DURGA
Add to calendar
Late breakers
December, 06th | 14:30 - 14:34
ABBV-RGX-314: A one-time in-office gene therapy for the treatment of diabetic retinopathy and the prevention of DME, PDR & other vision threatening complications
VAJZOVIC LEJLA
Add to calendar
ABBV-RGX-314: A one-time in-office gene therapy for the treatment of diabetic retinopathy and the prevention of DME, PDR & other vision threatening complications
VAJZOVIC LEJLA
Add to calendar
December, 06th | 14:34 - 14:38
New clinical and nonclinical analyses reveal silicone oil is associated with intraocular inflammation following intravitreal administration of Abicipar Pegol
KAISER PETER
Add to calendar
New clinical and nonclinical analyses reveal silicone oil is associated with intraocular inflammation following intravitreal administration of Abicipar Pegol
KAISER PETER
Add to calendar
December, 06th | 14:45 - 15:00
Session Awards - Newcomer of the Year Award - Most Innovative Science Award - Most Clinically Impactful Award
Add to calendar
Session Awards - Newcomer of the Year Award - Most Innovative Science Award - Most Clinically Impactful Award
Add to calendar
